Topical cosmetic compositions

A composition, technology for topical use in the field of topical compositions

Inactive Publication Date: 2017-02-22
MARY KAY INC
View PDF16 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The present inventors have identified a solution to the problems currently associated with products to counterac

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Topical cosmetic compositions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0108] Formulations containing the ingredients disclosed herein are formulated as topical skin and / or hair compositions. As a non-limiting example, the formulations in Table 1 were prepared as eye creams.

[0109] All compositions disclosed and claimed herein can be made and implemented in light of the present disclosure without undue experimentation. While the compositions and methods of the present invention have been described in terms of preferred embodiments, changes may be made in the compositions and in the steps or sequence of steps of the methods described herein without departing from the inventive concept, The spirit and scope will be apparent to those skilled in the art. More specifically, it is apparent that certain reagents, both chemically and physiologically related, could be substituted for the reagents described herein while achieving the same or similar results. All such similar substitutes and modifications apparent to those skilled in the art are deemed ...

Embodiment 2

[0115] (In Vitro Efficacy of Active Ingredients)

[0116] The potency of ingredients is determined by the following method. The following are non-limiting assays that can be used in the context of the present invention. It should be appreciated that other testing procedures may be used including, for example, objective and subjective procedures.

[0117] Centella asiatica extract was determined to promote hyaluronic acid synthesis, increase laminin production, inhibit melanin production, and decrease tyrosinase activity. It was also determined that Centella asiatica meristem cell cultures increased hyaluronic acid production and decreased tyrosinase activity. It was determined that lotus magnolia bark extract inhibits tumor necrosis factor alpha (TNFα), has antioxidant capacity, increases laminin production, and inhibits melanin production. It was determined that Magnolia officinalis bark extract provides antioxidant capacity, inhibits melanin production, inhibits expressio...

Embodiment 3

[0152] (Clinical Efficacy of Composition)

[0153] Appearance and Condition of Skin Around the Eyes - The compositions described in Table 1 have been shown in volunteer subjects to: increase skin firmness and elasticity; improve skin texture and clarity; reduce fine lines and / or wrinkles, Eye bags, dark circles, fine lines and sagging; improves the overall appearance of the eye area. The purpose of this study was to evaluate the efficacy of the compositions in Table 1 on aged / photoaged skin in the eye area. The study evaluated skin by visual grading and bioinstrumental measurements. It was determined that the compositions in Table 1 statistically increased skin firmness after 4 weeks of treatment and this increase was also detected at 12 weeks. The net elasticity of the skin also increased statistically at week 8. After 12 weeks, the following significant improvements were observed compared to baseline: improved skin texture and clarity; reduced fine lines and / or wrinkles, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a method useful for topical compositions and the compositions. The topical compositions comprise centella asiatica extract, magnolia grandiflora bark extract or magnolia officinalis bark extract, hespyridine methyl chalcone, pea extract, citrus grandis peel extract, magnolia biondii flower extract, dipeptide-2, palmitoyl tetrapeptide-7, tripeptide-1, and optionally centella asiatica meristematic cell culture. The invention also provides methods thereof for application and production.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of US Provisional Application No. 62 / 202568, filed August 7, 2015, the contents of which are incorporated herein by reference. technical field [0003] The present invention generally relates to topical compositions that can be used to improve the condition and / or visual appearance of the skin. In certain aspects, the compositions of the present invention may comprise, for example, ingredients to increase skin firmness and elasticity, improve skin texture and clarity, reduce skin inflammation, reduce skin pigmentation, Ingredients to reduce skin rashes, reduce fine lines and / or wrinkles, reduce eye bags, reduce dark circles, reduce fine lines and reduce sagging, brighten skin, treat rosacea , a combination of ingredients to improve the overall appearance of the eye area and ingredients to moisturize the skin and / or hair. The combination of ingredients can be included in a wide range ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K8/99A61K8/9789A61K8/06A61K8/60A61K8/64A61Q19/00A61Q19/02A61Q19/08
CPCA61K8/062A61K8/602A61K8/64A61K8/97A61K8/99A61K2800/782A61Q19/00A61Q19/005A61Q19/02A61Q19/08A61K8/064A61K8/9789A61K2800/522
Inventor 帕特里夏·雅各比蒂凡尼·卡尔米歇尔·海尼斯
Owner MARY KAY INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products